Pliant Therapeutics Inc
Pliant Therapeutics is a biotechnology company focused on discovering and developing novel therapies to treat fibrotic diseases.
Stock Performance Snapshot
Analyst Rating
Analysts suggest holding Pliant Therapeutics' stock with a target price of $41.08, indicating potential growth.
Financial Health
Pliant Therapeutics is performing adequately in terms of cash flow and book value per share.
View more stocks by downloading the app for FREE
It only takes 60 seconds.
Baskets Featuring PLRX
The Plasma Profit Pipeline
Biopharmaceutical leader CSL reported a 14% surge in annual profit, fueled by its plasma division's success. This highlights a growing investment opportunity in companies involved in the plasma-derived therapies market and the broader bioprocessing supply chain.
Published: August 19, 2025
Explore BasketWhy You’ll Want to Watch This Stock
Clinical‑stage focus
Programmes are at the clinical development stage, so trial readouts and regulatory steps are key catalysts — though results can be binary and unpredictable.
Fibrosis market potential
Fibrotic diseases represent a significant unmet medical need, offering potential upside if therapies prove effective, while commercial success is far from guaranteed.
Capital and timing
As a small‑cap company with a market cap ~ $115m, funding rounds and partnerships can change the outlook; investors should consider runway and dilution risk.
Why invest with Nemo?
Zero Commission
Trade stocks, ETFs, and more with zero commission. Keep more of your returns.
Trusted & Regulated
Part of Exinity Group 2015, serving over a million customers globally.
6% Interest on Cash
Earn 6% AER on uninvested cash with daily interest payments.
Discover More Opportunities
Eli Lilly and Company
Eli Lilly & Co is a global pharmaceutical company that develops, manufactures and markets human prescription drugs.
Johnson & Johnson
Johnson & Johnson is a multinational conglomerate pharmaceutical, medical devices, and consumer packaged goods company.
AbbVie Inc.
Abbvie is a research-based biopharmaceutical company that develops and markets advanced therapies to address complex medical conditions.
